Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Esophageal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Aspirin 2ficlatuzumab 1Vorinostat 1Raloxifene Hydrochloride 1Omeprazole 1Naproxen 1Febuxostat 1Erlotinib Hydrochloride 1Colchicine 1Bortezomib 1Allopurinol 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Cardiovascular Diseases × Raloxifene Hydrochloride × Clear all
NCT00190593 2007-01-26

Raloxifene Use for The Heart

Eli Lilly and Company

Phase 3 Completed
10,000 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡